Knight Therapeutics is a Montreal-based corporate strategic investor and specialty pharmaceutical company focused on biotechnology, life sciences and pharmaceuticals. It deploys capital through strategic lending, fund-level investments, licensing and commercialization partnerships, and seeks prescription pharmaceutical distribution rights in Canada and Latin America, with broader investment relevance across Israel, Australia, the Middle East, Sub-Saharan Africa and the Caribbean. It is best suited to healthcare companies or healthcare-focused fund managers seeking strategic capital and commercial partnership rather than a sector-agnostic VC.